加载中...

MedXY News - depression

MedXY AI/MedXY News/Tag: depression

MedXY News

EnglishTag

depression

37 all articles · 20 / page

Ask MedXY AI

clinical trial immunotherapy type 2 diabetes heart failure obesity clinical trials atrial fibrillation Cardiology biomarkers oncology cardiovascular risk public health Hypertension critical care Alzheimer's disease artificial intelligence breast cancer nutrition diabetes cardiovascular disease Pediatrics chronic kidney disease

Latest news

Tag

Semaglutide Shows Promise in Reducing Mental Illness Worsening in Patients with Depression and Anxiety, Swedish Study Finds

Semaglutide Shows Promise in Reducing Mental Illness Worsening in Patients with Depression and Anxiety, Swedish Study Finds

A landmark Swedish cohort study of 95,490 patients reveals that semaglutide is associated with a 42% lower risk of worsening mental illness in people with depression and anxiety, while other GLP-1 receptor agonists show varied effects. The

Section: Diabetes & EndocrinologyApr 13, 2026

Psychological Burden in Thyroid Cancer Survivorship: Real-World Evidence on Antidepressant Prescription Patterns

Psychological Burden in Thyroid Cancer Survivorship: Real-World Evidence on Antidepressant Prescription Patterns

A large-scale Korean cohort study reveals thyroid cancer survivors face a significantly higher risk of depression in the first five years post-diagnosis, independent of treatment modality or hormone dosage.

Section: Clinical UpdatesMar 18, 2026

Beyond the Bloat: Addressing the Neuropsychiatric Burden of Retrograde Cricopharyngeus Dysfunction through Targeted Botulinum Toxin Intervention

Beyond the Bloat: Addressing the Neuropsychiatric Burden of Retrograde Cricopharyngeus Dysfunction through Targeted Botulinum Toxin Intervention

This review analyzes the high prevalence of anxiety and depression in patients with Retrograde Cricopharyngeus Dysfunction (RCPD) and evaluates the significant, sustained mental health improvements following cricopharyngeal botulinum toxin

Section: Clinical UpdatesMar 13, 2026

Preparation Is Key: Study Finds Pre-Dose Therapy Hours Predict Success in Psychedelic-Assisted Therapy for Depression

Preparation Is Key: Study Finds Pre-Dose Therapy Hours Predict Success in Psychedelic-Assisted Therapy for Depression

A systematic review and meta-analysis of 12 clinical trials reveals that the quantity of preparation therapy—not post-dose integration—significantly predicts depressive symptom reduction in psychedelic-assisted therapy, highlighting the cri

Section: newsFeb 12, 2026

Adversity Across the Lifespan: The Compounding Impact of Childhood and Adult Stress on Dementia and Stroke Risk

Adversity Across the Lifespan: The Compounding Impact of Childhood and Adult Stress on Dementia and Stroke Risk

This population-based cohort study highlights how cumulative psychosocial stress across the life course significantly escalates the risk of neurovascular and neurodegenerative diseases, identifying depression as a critical target for interv

Section: NeurologyFeb 12, 2026

Scalable Digital Support Reduces Distress in Caregivers of Depressed Patients: Results from a Large-Scale RCT

Scalable Digital Support Reduces Distress in Caregivers of Depressed Patients: Results from a Large-Scale RCT

A large-scale randomized controlled trial reveals that online self-help programs, featuring either automated or individualized psychological support, significantly reduce the mental health burden on informal caregivers of people with depres

Section: newsJan 29, 2026

The Limits of Collaborative Care: Why the CLARO Trial Found No Added Benefit for OUD and Comorbid Mental Illness

The Limits of Collaborative Care: Why the CLARO Trial Found No Added Benefit for OUD and Comorbid Mental Illness

The CLARO randomized clinical trial investigated whether a collaborative care model could improve outcomes for patients with opioid use disorder and co-occurring depression or PTSD. The study found no statistically significant advantages ov

Section: Internal MedicineJan 1, 2026

Rule-Based Chatbots Outperform LLMs in Depressive Symptom Management: A Systematic Review and Meta-Analysis

Rule-Based Chatbots Outperform LLMs in Depressive Symptom Management: A Systematic Review and Meta-Analysis

A comprehensive meta-analysis indicates that rule-based chatbots provide a modest but statistically significant reduction in depressive symptoms within a 4-8 week window, whereas evidence for the clinical efficacy of Large Language Model (L

Section: AIDec 23, 2025

Adolescent Body Dissatisfaction as a Causal Driver of Adult Mental Health: New Insights from a UK Twin Study

Adolescent Body Dissatisfaction as a Causal Driver of Adult Mental Health: New Insights from a UK Twin Study

A longitudinal UK twin study suggests that adolescent body dissatisfaction may causally increase the risk of eating disorders and depression in young adulthood, with significant genetic factors underlying these associations.

Section: newsDec 20, 2025

Breaking the Cycle: How Modafinil Offers Hope for Sleep and Mood Disorders in HIV Patients

Breaking the Cycle: How Modafinil Offers Hope for Sleep and Mood Disorders in HIV Patients

Sleep disturbances and mood disorders profoundly affect people living with HIV. Modafinil emerges as a promising therapy addressing daytime sleepiness, depression, and cognitive challenges, improving quality of life.

Section: HIV/AIDSNov 12, 2025

How Much Aerobic Exercise Is Enough to Reduce Depression in Patients with Chronic Illness? A Dose–Response Meta-analysis Points to an Achievable Target

How Much Aerobic Exercise Is Enough to Reduce Depression in Patients with Chronic Illness? A Dose–Response Meta-analysis Points to an Achievable Target

A meta-analysis of 36 RCTs (n=2,500) found aerobic exercise significantly reduces depressive symptoms in people with chronic illness (Hedges’ g -0.73). A weekly dose of ≈405 MET‑min (≈120–135 min of moderate aerobic activity) reaches a mini

Section: Internal MedicineNov 8, 2025

Persistent Depressive Symptoms After MCI Strongly Predict Progression to Alzheimer’s Disease

Persistent Depressive Symptoms After MCI Strongly Predict Progression to Alzheimer’s Disease

In an ADNI longitudinal cohort, persistently elevated depressive symptoms over 36 months after MCI diagnosis were associated with a dose‑dependent, substantially higher hazard of conversion to Alzheimer’s disease over long-term follow-up.

Section: NeurologyNov 6, 2025

Hearing Aids Improve Some Aspects of Socio-Emotional Well‑being — But Not All: Insights from the WHAM Longitudinal Study

Hearing Aids Improve Some Aspects of Socio-Emotional Well‑being — But Not All: Insights from the WHAM Longitudinal Study

The WHAM longitudinal study finds modest psychosocial benefits from hearing‑aid uptake—reduced depression in people without tinnitus and lower loneliness in older adults—while showing limited mediation by self-perceived hearing disability a

Section: newsNov 4, 2025

Assessing Nearly Five Years of Real-World Safety Data on Esketamine Nasal Spray in the United States

Assessing Nearly Five Years of Real-World Safety Data on Esketamine Nasal Spray in the United States

A comprehensive evaluation of nearly five years of esketamine nasal spray use confirms its safety profile consistent with clinical trials, with no new safety signals detected in over 1.4 million treatment sessions.

Section: newsOct 30, 2025

Gamified mHealth Strategies Boost Treatment Adherence and Outcomes in Late-Life Depression

Gamified mHealth Strategies Boost Treatment Adherence and Outcomes in Late-Life Depression

Implementing gamification in mobile health psychotherapy markedly improves adherence and reduces depressive symptoms among older adults, offering a promising avenue to address mental health care needs in aging populations.

Section: newsOct 27, 2025

Long-Term Exposure to Air Pollution and Road Traffic Noise: Associations with Antidepressant Medication Dispensing in Swedish Adults

Long-Term Exposure to Air Pollution and Road Traffic Noise: Associations with Antidepressant Medication Dispensing in Swedish Adults

This review synthesizes evidence linking long-term air pollution and road traffic noise exposure with antidepressant medication dispensing, highlighting sex-specific associations and implications for mental health prevention strategies.

Section: Clinical UpdatesOct 23, 2025

Long-Term PM2.5 Exposure and Mental Health Disparities: Insights from the All of Us Research Program

Long-Term PM2.5 Exposure and Mental Health Disparities: Insights from the All of Us Research Program

This prospective study reveals that prolonged exposure to fine particulate matter (PM2.5) significantly elevates risks of depression and anxiety, disproportionately affecting Black populations due to systemic inequities. Findings call for t

Section: PsychiatryOct 23, 2025

Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link

Hyperemesis Gravidarum and Depression: Unveiling the Bidirectional Link

This comprehensive review examines the recent Finnish study highlighting the complex relationship between hyperemesis gravidarum and depression, emphasizing clinical implications for integrated mental health screening during reproductive ca

Section: OB/GYN & Women's HealthOct 19, 2025

Decoding the Optimal Aerobic Exercise Dose for Alleviating Depression in Youth: Evidence from a Meta-Analysis

Decoding the Optimal Aerobic Exercise Dose for Alleviating Depression in Youth: Evidence from a Meta-Analysis

Aerobic exercise significantly alleviates depressive symptoms in children and adolescents, especially in diagnosed adolescents, with 590 METs-min/week at moderate intensity identified as the optimal dose.

Section: newsOct 13, 2025

Coenzyme Q10 in Depression and Anxiety: Evaluating Therapeutic Potential Through Meta-Analysis

Coenzyme Q10 in Depression and Anxiety: Evaluating Therapeutic Potential Through Meta-Analysis

This meta-analysis examines Coenzyme Q10 supplementation’s impact on depression and anxiety, revealing modest benefits for depression at low doses and short durations but insufficient evidence for anxiety improvement.

Section: Internal MedicineOct 12, 2025